Upon hearing the SOS message from a patient, on war foot, we started organizing things to start the same to save a child with AML. Dr Terunuma Hiroshi, formerly was with the Tokyo Medical and Dental University Hospital working on Cell Biology and Immunology was our collaborator in this venture and he immediately started helping us with every thing we needed to start the Autologous Immune Enhancement Therapy in India. To formalize this collaboration, a formal MoU was signed among M/S Nichi-In Centre for Regenerative Medicine, India and M/S Biotherapy Institute, Japan.
The Biotherapy Institute is having three state-of-the-art clinical cell processing units as per cGMP standards in Tokyo with more than 50 scientists and research officers working there. They have clinical affiliation with several hospitals in and around Tokyo city for offering the Immunotherapy. They have crossed more than 1000 cases of Immunotherapy till date with very good results.
Dr. Terunuma Hiroshi, the scientific head of the institute has more than 100 publications in this specialty to his credit and also a couple of patents.